AYTU BIOSCIENCE, INC | Business Contracts

Description of Securities (Filed With SEC on September 27, 2022)

Form of Common Warrant (Filed With SEC on August 10, 2022)

Form of Indemnification Agreement (Filed With SEC on July 1, 2022)

Employment Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)

Option and Exclusive License Agreement between Rumpus VEDS, LLC and Denovo Biopharma LLC, dated December 21, 2019 (Filed With SEC on May 17, 2021)

Agreement and Plan of Merger, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neutron Acquisition Sub, Inc. and Neos Therapeutics, Inc (Filed With SEC on December 10, 2020)

Lease amendment between Aytu BioScience, Inc. and Beta Investors Group, LLC (Filed With SEC on May 14, 2019)

Form of Pre-Funded Warrant (Filed With SEC on August 10, 2022)

Underwriting Agreement dated August 9, 2022 (Filed With SEC on August 10, 2022)

Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (Filed With SEC on May 16, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)

Form of Prefunded Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)

Underwriting Agreement, dated as of March 2, 2022, by and between Aytu BioPharma, Inc. and Canaccord Genuity LLC (Filed With SEC on March 4, 2022)

Restricted Stock Award Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)

Loan and Security Agreement dated January 26, 2022 between the registrant and the Avenue Capital Lenders and Avenue Capital Agent (Filed With SEC on February 14, 2022)

Closing Certificate with respect to the July 1, 2021 Asset Purchase Agreement, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)

Promissory Note, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)

Termination Agreement, dated June 29, 2021 by and between Aytu BioPharma, Inc. and Avrio Genetics, LLC (Filed With SEC on September 28, 2021)

Asset Purchase Agreement, dated July 1, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on September 28, 2021)

Controlled Equity OfferingSM Sales Agreement, dated June 4, 2021, by and between Aytu BioPharma, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 7, 2021)

Separation Agreement between Aytu BioPharma, Inc. and David A. Green, dated March 31, 2021 (Filed With SEC on May 17, 2021)

Asset Purchase Agreement, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Indemnification Agreement between Aytu BioPharma, Inc. and Gerald McLaughlin, dated March 19, 2021 (Filed With SEC on May 17, 2021)

Indemnification Agreement between Aytu BioPharma, Inc. and Beth P. Hecht, dated March 19, 2021 (Filed With SEC on May 17, 2021)

Termination and Transition Agreement between Aytu BioPharma, Inc. and Acerus Pharmaceuticals Corporation, dated March 31, 2021 (Filed With SEC on May 17, 2021)

Employment Agreement between Aytu BioPharma, Inc. and Christopher Brooke, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Second Amendment to Employment Agreement with Joshua R. Disbrow dated April 7, 2021 (Filed With SEC on May 17, 2021)

Employment Agreement between Aytu BioPharma, Inc. and Nathaniel Massari, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Exclusive License Agreement between Rumpus VEDS, LLC and Johns Hopkins University, dated December 20, 2019 (Filed With SEC on May 17, 2021)

EMPLOYMENT AGREEMENT (Filed With SEC on April 5, 2021)

Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)

Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)

License Agreement with Avrio Genetics, LLC, dated January 20, 2020 (Filed With SEC on February 11, 2021)

Form of Underwriter Warrants (Filed With SEC on December 14, 2020)

Amended and Restated Underwriting Agreement, dated December 10, 2020, between Aytu BioScience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 14, 2020)

Form of Neos Stockholder Voting Agreement (Filed With SEC on December 10, 2020)

Form of Aytu Stockholder Voting Agreement (Filed With SEC on December 10, 2020)

Commitment Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and Encina Business Credit, LLC (Filed With SEC on December 10, 2020)

Deerfield Consent Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and the lenders party thereto (Filed With SEC on December 10, 2020)

Commitment Letter, dated as of December 10, 2020, by and between Aytu BioScience, Inc. and Neos Therapeutics, Inc (Filed With SEC on December 10, 2020)

Amended Employment Agreement with David A. Green dated July 1, 2020 (Filed With SEC on October 6, 2020)

Amended Employment Agreement with Joshua R. Disbrow dated July 1, 2020 (Filed With SEC on October 6, 2020)

Form of Restricted Stock Cancelation and Exchange Agreement (Filed With SEC on July 2, 2020)

Form of Wainwright Warrant (Filed With SEC on July 2, 2020)

Early Payment Agreement, dated May 29, 2020 (Filed With SEC on June 1, 2020)

Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 20, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 20, 2020)

Form of Warrant (Filed With SEC on March 20, 2020)

Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 13, 2020)

Form of Warrant (Filed With SEC on March 13, 2020)

Form of Securities Purchase Agreement, dated March 10, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 13, 2020)

Form of Pre-Funded Purchase Warrant (Filed With SEC on March 13, 2020)

First Amendment to Merger Purchase Agreement, dated January 9, 2020 (Filed With SEC on January 15, 2020)

Waiver and Amendment to the July 29, 2019 Amended and Restated License and Supply Agreement (Filed With SEC on December 2, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 7, 2019)

Registration Rights Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Officer Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

First Amendment to Asset Purchase Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Cerecor Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Transition Services Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Security Holder Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Registration Rights Agreement (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)

Placement Agency Agreement, dated October 11, 2019 (Filed With SEC on October 15, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on October 15, 2019)

Asset Purchase Agreement, dated October 10, 2019 (Filed With SEC on October 15, 2019)

Agreement and Plan of Merger, dated as of September 12, 2019, by and among Aytu BioScience, Inc., Aytu Acquisition Sub, Inc. and Innovus Pharmaceuticals, Inc (Filed With SEC on September 18, 2019)

Form of Contingent Value Rights Agreement (Filed With SEC on September 18, 2019)

AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS CORPORATION and AYTU BIOSCIENCE, INC. Dated as of July 29, 2019 (Filed With SEC on August 2, 2019)

Employment Agreement, effective April 16, 2019, between Aytu BioScience, Inc. and Jarrett T. Disbrow (Filed With SEC on May 14, 2019)

Employment Agreement, effective April 16, 2019, between Aytu BioScience, Inc. and Joshua R. Disbrow (Filed With SEC on May 14, 2019)

Independent Contractor Services Agreement dated as of May 1, 2019, by and between Aytu BioScience, Inc. and Averaden, LLC (Filed With SEC on May 2, 2019)

Form of Amendment No. 1 to Securities Purchase Agreement, dated April 24, 2019 (Filed With SEC on April 26, 2019)

Form of Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (Filed With SEC on February 7, 2019)

Exchange Agreement dated February 5, 2019 (Filed With SEC on February 7, 2019)

Form of Warrant (Filed With SEC on February 7, 2019)

Waiver of Blocker dated February 5, 2019 (Filed With SEC on February 7, 2019)

License, Development, Manufacturing and Supply Agreement dated November 2, 2018 between Aytu BioScience, Inc. and TRIS Pharma, Inc (Filed With SEC on February 7, 2019)

AYTU BIOSCIENCE, INC (82)